BARCLAYS PLC - ELOXX PHARMACEUTICALS INC ownership

ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 42 filers reported holding ELOXX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ELOXX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$6,000
-53.8%
3,678
-43.0%
0.00%
Q2 2021$13,000
-82.4%
6,453
-71.0%
0.00%
Q1 2021$74,000
+117.6%
22,278
+159.0%
0.00%
Q4 2020$34,000
+9.7%
8,601
-29.1%
0.00%
Q3 2020$31,000
-31.1%
12,133
-16.7%
0.00%
Q2 2020$45,000
+181.2%
14,564
+74.3%
0.00%
Q1 2020$16,000
-91.4%
8,356
-67.2%
0.00%
Q4 2019$187,000
+216.9%
25,438
+93.3%
0.00%
Q3 2019$59,000
-59.6%
13,158
-10.1%
0.00%
Q2 2019$146,000
+65.9%
14,630
+93.9%
0.00%
Q1 2019$88,000
-38.5%
7,546
-10.2%
0.00%
Q3 2018$143,000
+429.6%
8,406
+433.0%
0.00%
Q2 2018$27,0001,5770.00%
Other shareholders
ELOXX PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 1,950,949$1,092,0000.45%
AMERICAN FINANCIAL GROUP INC 1,480,000$829,0000.25%
Vanguard Capital Wealth Advisors 158,900$86,0000.06%
Atom Investors LP 113,151$63,0000.03%
Nantahala Capital Management 774,767$434,0000.02%
MENORA MIVTACHIM HOLDINGS LTD. 2,094,208$1,173,0000.02%
Harel Insurance Investments & Financial Services Ltd. 1,176,401$659,0000.01%
Altshuler Shaham Ltd 1,088,848$609,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 309,400$173,0000.00%
Clal Insurance Enterprises Holdings Ltd 585,000$328,0000.00%
View complete list of ELOXX PHARMACEUTICALS INC shareholders